Spatial patterns of immune cell states are associated with poor response to neoadjuvant chemotherapy in high-grade serous ovarian cancer

被引：0
|
作者：
Niemiec, Iga
Kahelin, Essi
Liang, Zhihan
Erkan, Erdogan P.
Vaharautio, Anna
Virtanen, Anni
Farkkila, Anniina
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 05期
关键词：
D O I：
10.1158/1538-7445.OVARIAN23-B077
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B077
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Cell Origins of High-Grade Serous Ovarian Cancer
    Kim, Jaeyeon
    Park, Eun Young
    Kim, Olga
    Schilder, Jeanne M.
    Coffey, Donna M.
    Cho, Chi-Heum
    Bast, Robert C., Jr.
    CANCERS, 2018, 10 (11)
  • [22] Effect of chemotherapy on immune infiltration status and immune pathway activation in high-grade serous ovarian cancer
    LaVigne, K.
    Jimenez-Sanchez, A.
    Cybulska, P.
    Chi, D. S.
    Park, K. J.
    Walther, T.
    Miller, M.
    Snyder, A.
    GYNECOLOGIC ONCOLOGY, 2018, 149 : 53 - 53
  • [23] Effects of neoadjuvant hyperthermic intraperitoneal chemotherapy on chemotherapy response score and recurrence for high-grade serous ovarian cancer patients with advanced disease
    Li, J.
    Wu, M-F.
    Li, H.
    Lin, Z-Q.
    Wang, L-J.
    ANNALS OF ONCOLOGY, 2020, 31 : S1336 - S1336
  • [24] Dynamics of the Intratumoral Immune Response during Progression of High-Grade Serous Ovarian Cancer
    Stanske, Mandy
    Wienert, Stephan
    Castillo-Tong, Dan Cacsire
    Kreuzinger, Caroline
    Vergote, Ignace
    Lambrechts, Sandrijne
    Gabra, Hani
    Gourley, Charlie
    Ganapathi, Ram N.
    Kolaschinski, Ivonne
    Budczies, Jan
    Sehouli, Jalid
    Ruscito, Ilary
    Denkert, Carsten
    Kulbe, Hagen
    Schmitt, Wolfgang
    Johrens, Korinna
    Braicu, Ioana
    Darb-Esfahani, Silvia
    NEOPLASIA, 2018, 20 (03): : 280 - 288
  • [25] Properties of the immune microenvironment associated with clonal diversity in high-grade serous ovarian cancer
    Zhang, Allen W.
    McPherson, Andrew
    Roth, Andrew
    Kroeger, David R.
    Milne, Katy
    Wasserman, Wyeth W.
    McAlpine, Jessica N.
    Holt, Robert A.
    Nelson, Brad H.
    Shah, Sohrab P.
    CANCER RESEARCH, 2016, 76
  • [26] Genomic profiling of the residual disease of advanced high-grade serous ovarian cancer after neoadjuvant chemotherapy
    Lee, Yong J.
    Kim, Dachan
    Shim, Jung E.
    Bae, Su-Jin
    Jung, Yu-Jin
    Kim, Sora
    Lee, Hanna
    Kim, So H.
    Jo, Su B.
    Lee, Jung-Yun
    Kim, Hyun-Soo
    Paik, Soonmyung
    INTERNATIONAL JOURNAL OF CANCER, 2020, 146 (07) : 1851 - 1861
  • [27] New prognostic index for neoadjuvant chemotherapy outcome in patients with advanced high-grade serous ovarian cancer
    Huo, Chuying
    Wu, Bin
    Ye, Dongdong
    Xu, Miaochun
    Ma, Shaolin
    Cheng, Aoshuang
    Liu, Yunyun
    Huang, Chunxian
    Zhang, Yuhao
    Lin, Zhongqiu
    Li, Bowen
    Lu, Huaiwu
    BMC CANCER, 2024, 24 (01)
  • [28] Genomic profiling of the residual disease of advanced high-grade serous ovarian cancer after neoadjuvant chemotherapy
    Lee, J-Y.
    Paik, S.
    ANNALS OF ONCOLOGY, 2018, 29
  • [29] Neoadjuvant treatment as a window to chemotherapy driven alterations to the genome and transcriptome of high-grade serous ovarian cancer
    Javellana, Melissa
    Eckert, Mark
    Stock, Elizabeth
    Chapel, David
    Lastra, Ricardo
    Lengyel, Ernst
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S210 - S210
  • [30] Integrated radiogenomics models predict response to neoadjuvant chemotherapy in high grade serous ovarian cancer
    Mireia Crispin-Ortuzar
    Ramona Woitek
    Marika A. V. Reinius
    Elizabeth Moore
    Lucian Beer
    Vlad Bura
    Leonardo Rundo
    Cathal McCague
    Stephan Ursprung
    Lorena Escudero Sanchez
    Paula Martin-Gonzalez
    Florent Mouliere
    Dineika Chandrananda
    James Morris
    Teodora Goranova
    Anna M. Piskorz
    Naveena Singh
    Anju Sahdev
    Roxana Pintican
    Marta Zerunian
    Nitzan Rosenfeld
    Helen Addley
    Mercedes Jimenez-Linan
    Florian Markowetz
    Evis Sala
    James D. Brenton
    Nature Communications, 14
12345